LEXX
Lexaria Bioscience Corp
NASDAQ: LEXX · HEALTHCARE · BIOTECHNOLOGY
$0.66
-4.34% today
Updated 2026-04-30
Market cap
$23.56M
P/E ratio
—
P/S ratio
64.01x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Lexaria Bioscience Corp (LEXX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+16.7%
Last 4 quarters
Revenue YoY growth
-88.5%
Most recent quarter
EPS YoY growth
+60.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.5%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+11.1%
2026-01-21
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-14 | $-0.06 | +50.0% | $0.98 | $1.03 | +5.1% |
| 2026-01-21 | $-0.10 | +41.2% | $0.74 | $0.82 | +11.1% |
| 2025-10-29 | $-0.14 | +9.7% | $0.95 | $0.98 | +3.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-02-28 | $-0.12 | $-0.06 | +50.0% | $20000.00 | -88.5% |
| 2025-11-30 | $-0.17 | $-0.10 | +41.2% | — | — |
| 2025-08-31 | $-0.16 | $-0.14 | +9.7% | $174000.00 | +107.1% |
| 2025-05-31 | $-0.16 | $-0.21 | -34.0% | $174000.00 | +107.1% |
| 2025-02-28 | $-0.16 | $-0.15 | +8.1% | $174000.00 | +20.0% |
| 2024-11-30 | $-0.12 | $-0.16 | -33.3% | $183923.00 | +21.6% |
| 2024-08-31 | $-0.11 | $-0.15 | -36.4% | $84000.00 | +173.3% |
| 2024-05-31 | $-0.10 | $-0.13 | -30.0% | $84000.00 | — |
| 2024-02-29 | $-0.10 | $-0.06 | +40.0% | $145000.00 | — |
| 2023-11-30 | $-0.11 | $-0.13 | -18.2% | $151278.00 | — |
| 2023-08-31 | $-0.13 | $-0.12 | +7.7% | $30741.00 | — |
Frequently asked questions
Has Lexaria Bioscience Corp beaten earnings estimates?
Lexaria Bioscience Corp has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +16.7% over the last 4 quarters.
How does LEXX stock react to earnings?
LEXX stock has moved an average of +6.5% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Lexaria Bioscience Corp's revenue growth rate?
Lexaria Bioscience Corp reported year-over-year revenue growth of -88.5% in its most recent quarter, with EPS growing +60.0% year-over-year.